Syncom Formulation (India) Ltd

SYNCOMF

Company Profile

  • Business description

    Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

  • Contact

    207, Saket Nagar
    Near Saket Club
    IndoreMP452018
    IND

    T: +91 7312560458

    https://www.sfil.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    2,122

Stocks News & Analysis

stocks

Eli Lilly receives FDA approval to add another oral GLP-1 to market

Wide moat Eli Lilly receives FDA approval for obesity pill.
stocks

Our top ASX picks in every sector

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks

Which of the 3 giant AI IPOs should you buy?

OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,774.90124.80-1.40%
CAC 407,896.4484.83-1.06%
DAX 4022,889.17409.72-1.76%
Dow JONES (US)46,100.96464.78-1.00%
FTSE 10010,378.5013.710.13%
HKSE25,116.53177.50-0.70%
NASDAQ21,613.79227.15-1.04%
Nikkei 22552,463.271,276.41-2.38%
NZX 50 Index12,902.1576.280.59%
S&P 5006,522.7552.57-0.80%
S&P/ASX 2008,579.50105.50-1.21%
SSE Composite Index3,919.2929.27-0.74%

Market Movers